Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study

医学 克罗恩病 内科学 队列 疾病 并发症 英夫利昔单抗 前瞻性队列研究 炎症性肠病 队列研究 危险系数 外科 胃肠病学 置信区间
作者
Subra Kugathasan,Lee A. Denson,Thomas D. Walters,Mi‐Ok Kim,Urko M. Marigorta,Melanie Schirmer,Kajari Mondal,Chunyan Liu,Anne M. Griffiths,Joshua D. Noe,Wallace Crandall,Scott B. Snapper,Shervin Rabizadeh,Joel R. Rosh,Jason M. Shapiro,Stephen L. Guthery,David R. Mack,Richárd Kellermayer,Michael D. Kappelman,Steven J. Steiner
出处
期刊:The Lancet [Elsevier BV]
卷期号:389 (10080): 1710-1718 被引量:642
标识
DOI:10.1016/s0140-6736(17)30317-3
摘要

Background Stricturing and penetrating complications account for substantial morbidity and health-care costs in paediatric and adult onset Crohn's disease. Validated models to predict risk for complications are not available, and the effect of treatment on risk is unknown. Methods We did a prospective inception cohort study of paediatric patients with newly diagnosed Crohn's disease at 28 sites in the USA and Canada. Genotypes, antimicrobial serologies, ileal gene expression, and ileal, rectal, and faecal microbiota were assessed. A competing-risk model for disease complications was derived and validated in independent groups. Propensity-score matching tested the effect of anti-tumour necrosis factor α (TNFα) therapy exposure within 90 days of diagnosis on complication risk. Findings Between Nov 1, 2008, and June 30, 2012, we enrolled 913 patients, 78 (9%) of whom experienced Crohn's disease complications. The validated competing-risk model included age, race, disease location, and antimicrobial serologies and provided a sensitivity of 66% (95% CI 51–82) and specificity of 63% (55–71), with a negative predictive value of 95% (94–97). Patients who received early anti-TNFα therapy were less likely to have penetrating complications (hazard ratio [HR] 0·30, 95% CI 0·10–0·89; p=0·0296) but not stricturing complication (1·13, 0·51–2·51; 0·76) than were those who did not receive early anti-TNFα therapy. Ruminococcus was implicated in stricturing complications and Veillonella in penetrating complications. Ileal genes controlling extracellular matrix production were upregulated at diagnosis, and this gene signature was associated with stricturing in the risk model (HR 1·70, 95% CI 1·12–2·57; p=0·0120). When this gene signature was included, the model's specificity improved to 71%. Interpretation Our findings support the usefulness of risk stratification of paediatric patients with Crohn's disease at diagnosis, and selection of anti-TNFα therapy. Funding Crohn's and Colitis Foundation of America, Cincinnati Children's Hospital Research Foundation Digestive Health Center. Stricturing and penetrating complications account for substantial morbidity and health-care costs in paediatric and adult onset Crohn's disease. Validated models to predict risk for complications are not available, and the effect of treatment on risk is unknown. We did a prospective inception cohort study of paediatric patients with newly diagnosed Crohn's disease at 28 sites in the USA and Canada. Genotypes, antimicrobial serologies, ileal gene expression, and ileal, rectal, and faecal microbiota were assessed. A competing-risk model for disease complications was derived and validated in independent groups. Propensity-score matching tested the effect of anti-tumour necrosis factor α (TNFα) therapy exposure within 90 days of diagnosis on complication risk. Between Nov 1, 2008, and June 30, 2012, we enrolled 913 patients, 78 (9%) of whom experienced Crohn's disease complications. The validated competing-risk model included age, race, disease location, and antimicrobial serologies and provided a sensitivity of 66% (95% CI 51–82) and specificity of 63% (55–71), with a negative predictive value of 95% (94–97). Patients who received early anti-TNFα therapy were less likely to have penetrating complications (hazard ratio [HR] 0·30, 95% CI 0·10–0·89; p=0·0296) but not stricturing complication (1·13, 0·51–2·51; 0·76) than were those who did not receive early anti-TNFα therapy. Ruminococcus was implicated in stricturing complications and Veillonella in penetrating complications. Ileal genes controlling extracellular matrix production were upregulated at diagnosis, and this gene signature was associated with stricturing in the risk model (HR 1·70, 95% CI 1·12–2·57; p=0·0120). When this gene signature was included, the model's specificity improved to 71%. Our findings support the usefulness of risk stratification of paediatric patients with Crohn's disease at diagnosis, and selection of anti-TNFα therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
秋风的应助被无趣采纳,获得10
1秒前
脑洞疼的应助被无趣采纳,获得10
1秒前
sufu_jony的应助被无趣采纳,获得10
1秒前
1秒前
1秒前
满意妙梦发布了新的文献求助10
1秒前
2秒前
fy发布了新的文献求助10
2秒前
活力的幻露完成签到,获得积分10
3秒前
我是老大的应助被明亮白山采纳,获得10
4秒前
6秒前
隐形曼青的应助被现代胡萝卜采纳,获得30
6秒前
榴莲发布了新的文献求助10
7秒前
学习发布了新的文献求助10
7秒前
穆有问题完成签到,获得积分10
8秒前
英姑的应助被初景采纳,获得150
8秒前
调皮芝麻完成签到,获得积分10
8秒前
8秒前
SciGPT的应助被哈基米德采纳,获得10
9秒前
赘婿的应助被羡鱼采纳,获得10
9秒前
Eliauk发布了新的文献求助50
9秒前
板凳饭团完成签到,获得积分10
10秒前
Nole的应助被11采纳,获得30
12秒前
DW的应助被Olive采纳,获得10
12秒前
13秒前
13秒前
满意妙梦完成签到,获得积分10
13秒前
无趣完成签到,获得积分20
14秒前
14秒前
一生所爱发布了新的文献求助10
15秒前
ff完成签到,获得积分10
15秒前
xiejingyu发布了新的文献求助10
16秒前
酷波er的应助被DREAMING采纳,获得10
16秒前
16秒前
刘刘宇航完成签到,获得积分20
18秒前
濯枝雨完成签到 ,获得积分10
18秒前
斯文败类的应助被LIUDAN采纳,获得10
19秒前
19秒前
RUSH发布了新的文献求助20
19秒前
灵巧的乌发布了新的文献求助10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183694
求助须知:如何正确求助?哪些是违规求助? 9572963
关于积分的说明 21828306
捐赠科研通 7780864
什么是DOI,文献DOI怎么找? 3434057
关于科研通互助平台的介绍 2558257
邀请新用户注册赠送积分活动 2480541